In order to get more accurate results, our search has the following Google-Type search functionality:
If you use '+' in front of a word, then that word will be present in the search results.
ex: Harry +Potter will return results with the word 'Potter'.
If you use '-' in front of a word, then that word will be absent in the search results.
ex: Harry -Potter will return results without the word 'Potter'.
If you use 'AND' between two words, then both of those words will be present in the search results.
ex: Harry AND Potter will return results with both 'Harry' and 'Potter'.
If you use 'OR' between two words, then bth of those words may or may not be present in the search results.
ex: Harry OR Potter will return results with just 'Harry', results with just 'Potter' and results with both 'Harry' and 'Potter'.
If you use 'NOT' before a word, then that word will be absent in the search results.
ex: Harry NOT Potter will return results without the word 'Potter'.
Placing '""' around words will perform a phrase search. The search results will contain those words in that order.
ex: "Harry Potter" will return any results with 'Harry Potter' in them, but not 'Potter Harry'.
Using '*' in a word will perform a wildcard search. The '*' signifies any number of characters. Searches can not start with a wildcard.
ex: Pot*er will return results with words starting with 'Pot' and ending in 'er'. In this case, 'Potter' will be a match.
|
|
|||
|
||||
OverviewDepuis ces vingt derni res ann es, suite l'apparition de nombreuses r sistances aux traitements anticanc reux classiques, les th rapeutiques anticanc reuses sont en plein remaniement. Ces nouveaux d veloppements visent atteindre les m canismes m me de l'oncogen se. Le nom de th rapie cibl e fait r f rence ce ciblage de l'oncogen se. Gr ce aux nombreux progr?'s r alis?'s dans le domaine de la biologie tumorale, cinq m canismes fondamentaux de l' uvre dans l'oncogen se ont t r pertori s. On trouve ainsi, la prolif ration cellulaire incontr l e, la perte de contr le de capacit de mort cellulaire programm e (apoptose), l'acquisition d'une immortalit des lign es cellulaires, le d veloppement des capacit?'s d'invasion et de m tastases, et enfin, la mise en place d'une angiogen se sp cifique la tumeur. Toutes ces pistes ont t tudi es pour trouver de nouveaux agents anticanc reux. Les r sultats obtenus gr ce ces nouvelles mol cules varient selon la cible choisie, mais certaines d'entre elles font d'ores et d j parties des protocoles de traitement des cancers. Full Product DetailsAuthor: Elise DongmoPublisher: Editions Universitaires Europeennes Imprint: Editions Universitaires Europeennes Country of Publication: United States Dimensions: Width: 15.20cm , Height: 1.00cm , Length: 22.90cm Weight: 0.259kg ISBN: 9786131592164ISBN 10: 6131592160 Pages: 172 Publication Date: 12 October 2011 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Not yet available  This item is yet to be released. You can pre-order this item and we will dispatch it to you upon it's release. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
Log In
Register/Sign Up
Customer Log In
